A new cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) shows that a drug that utilizes the body's ...
The company will hold off on making a regulatory decision until it sees results from another trial testing the drug with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback